Tackling the Serious Global Challenges in Infectious Disease
Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases
Appili leadership is experienced in drug development, infectious disease, business development, and commercialization.
The Appili team fuels innovation by balancing the company’s pipeline with near-to-market opportunities with transformational programs designed to tackle the most serious threats.
Advancing infectious disease drug development programs to provide solutions to patients, doctors, and society.
